Similar Articles
1261 MT1M and MT1G promoter methylation as biomarkers for hepatocellular carcinoma
1262 Hepatocellular carcinoma review: Current treatment, and evidence-based medicine
1263 Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma
1264 Staging systems of hepatocellular carcinoma: A review of literature
1265 Chemotherapy for advanced hepatocellular carcinoma in the sorafenib age
1266 Anatomic resection of liver segments 6-8 for hepatocellular carcinoma
1267 New approaches for precise response evaluation in hepatocellular carcinoma
1268 Transarterial chemoembolization and bland embolization for hepatocellular carcinoma
1269 Oxidative damage in the progression of chronic liver disease to hepatocellular carcinoma: An intricate pathway
1270 Systemic therapy of hepatocellular carcinoma: Current status and future perspectives
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA